Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist. - Wikidata - wikimedia - TriplyDB

Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist.

Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist.

http://www.wikidata.org/entity/Q34531671

about

Immunomodulation in sepsis: state of the art and future perspective The Toll of Vascular Insufficiency: Implications for the Management of Peripheral Arterial Disease Targeting toll-like receptors: promising therapeutic strategies for the management of sepsis-associated pathology and infectious diseases A quantitative comparison of single-dye tracking analysis tools using Monte Carlo simulations An unusual dimeric structure and assembly for TLR4 regulator RP105–MD-1 Dual inhibition of complement and Toll-like receptors as a novel approach to treat inflammatory diseases-C3 or C5 emerge together with CD14 as promising targets Bartonella quintana lipopolysaccharide (LPS): structure and characteristics of a potent TLR4 antagonist for in-vitro and in-vivo applications Evidence of a specific interaction between new synthetic antisepsis agents and CD14.Toll-like receptor 4 and hepatic fibrogenesis Partially glycosylated dendrimers block MD-2 and prevent TLR4-MD-2-LPS complex mediated cytokine responses.TLR4 dependent heparan sulphate-induced pancreatic inflammatory response is IRF3-mediated Amelioration of acute kidney injury in lipopolysaccharide-induced systemic inflammatory response syndrome by an aldose reductase inhibitor, fidarestat.Therapeutic interventions in sepsis: current and anticipated pharmacological agents Eritoran: the evidence of its therapeutic potential in sepsis The role of Toll-like receptors in the regulation of neutrophil migration, activation, and apoptosis.Lead increases lipopolysaccharide-induced liver-injury through tumor necrosis factor-alpha overexpression by monocytes/macrophages: role of protein kinase C and P42/44 mitogen-activated protein kinase.Eritoran tetrasodium (E5564) treatment for sepsis: review of preclinical and clinical studies.Toll-like receptors 2 and 4: initiators of non-septic inflammation in critical care medicine?Novel drugs targeting Toll-like receptors for antiviral therapy.Modeling Human Respiratory Viral Infections in the Cotton Rat (Sigmodon hispidus).Toll-like receptor 4 (TLR4) antagonist eritoran tetrasodium attenuates liver ischemia and reperfusion injury through inhibition of high-mobility group box protein B1 (HMGB1) signaling.Recent developments in the identification of novel therapeutic targets for the treatment of patients with sepsis and septic shock.From agonist to antagonist: structure and dynamics of innate immune glycoprotein MD-2 upon recognition of variably acylated bacterial endotoxins Pharmacological TLR4 Inhibition Protects against Acute and Chronic Fat-Induced Insulin Resistance in Rats Synthesis and characterization of a dipalmitoylated lipopeptide derived from paralogous lipoproteins of Mycoplasma pneumoniae.Discovery and Structure-Activity Relationships of the Neoseptins: A New Class of Toll-like Receptor-4 (TLR4) Agonists.Inflammation--a new therapeutic target in pneumonia.Update on toll-like receptor-directed therapies for human disease DNA-Containing Immunocomplexes Promote Inflammasome Assembly and Release of Pyrogenic Cytokines by CD14+ CD16+ CD64high CD32low Inflammatory Monocytes from Malaria Patients.Energetics of Endotoxin Recognition in the Toll-Like Receptor 4 Innate Immune Response.Mechanisms of Toll-like Receptor 4 Endocytosis Reveal a Common Immune-Evasion Strategy Used by Pathogenic and Commensal Bacteria.Sensing gram-negative bacterial lipopolysaccharides: a human disease determinant?Toll-like Receptors in the Vascular System: Sensing the Dangers Within.Selection, synthesis, and anti-inflammatory evaluation of the arylidene malonate derivatives as TLR4 signaling inhibitors TLR4 signaling mediates inflammation and tissue injury in nephrotoxicity.Bench-to-bedside review: sepsis, severe sepsis and septic shock - does the nature of the infecting organism matter?Dysregulation of human Toll-like receptor function in aging.Cbl-b is a critical regulator of macrophage activation associated with obesity-induced insulin resistance in mice.The TLR4 antagonist Eritoran protects mice from lethal influenza infection.Protective effects of Sparstolonin B, a selective TLR2 and TLR4 antagonist, on mouse endotoxin shock

P2860

Q22305766-BA1BCC6D-F239-4A94-B0BC-BD377AF58F55 Q26753079-8AA19D57-E304-485B-956B-621B71ADD723 Q27010345-48F91F6B-6C01-449F-9744-5FC569A468A5 Q27319086-50FB6F60-9ED9-4C15-BD65-A7A605586578 Q27671851-977144CC-72E1-4EF6-9852-F8A9890D11B3 Q28077955-04E78A62-08A2-4E59-BB4F-7E58A58D1570 Q28828935-5616CE2B-3FEC-4311-A38F-951B2F6E0784 Q33575108-BDD4F0B6-6ADD-4171-BFBE-10681768C8CB Q33905721-2D8FF819-4454-43AE-8403-4EE21658D731 Q33954358-A33503ED-64A5-4115-A58B-C929DB7F7394 Q34107852-38D66743-DD3A-4AB3-A599-32001C3D1FE5 Q34131121-882994EB-A349-4F37-B1E8-A0150FAAE085 Q34427050-D106ADA0-7FCA-4085-92CF-F7C234759259 Q34449865-087BAAFB-9316-4C9D-B8FA-10F799DD606D Q34461296-8354ED26-CF46-4EEF-92DE-8CD94BDD10D4 Q34547090-7882A8AE-8BE9-410E-9609-78EBFB5CAFFC Q34726541-D7B47604-A8CD-4D3C-812F-00F55E1AD19B Q34956130-A0BFCD73-3EAA-4673-B9B4-1273E6FFAB01 Q34999938-B59BB25C-2979-4574-A3BF-FC4699631F90 Q35017599-291ACBFB-06C5-4CA0-8C53-89051E3BB87B Q35192812-7A21979D-ACB3-44B4-A8FA-F2755BA350A9 Q35585111-6CCB4636-134A-4C10-A492-429D498257A8 Q35657133-937A34EF-629E-4DFE-A975-379DBBA930B9 Q35702671-4FBC8FD7-6BED-4A69-94B2-1E3B775CBD8D Q35784146-20812B3D-7256-4E9F-8A22-EE68E97F9A2D Q35981265-E518F6DC-91DC-4F3A-B909-731C69299C3E Q36095647-6F90F167-9CA3-4CE3-B1EE-2231FE462913 Q36171745-0924DEC5-42E7-4089-BBB1-3D1018E2B199 Q36318958-3E1FF2D2-69C5-4311-94DA-8485E98A512A Q36357406-363A1402-1895-4B71-80A0-F5D51722F66E Q36388377-C49F187E-0125-46FA-A918-12EF6DD2E1DD Q36421502-9C587A3E-8192-4FE7-B39C-58393EA83100 Q36453194-07493AB5-852E-441F-BC29-D3A7DBF0DA9F Q36453211-23A9CE48-9A3B-407B-AC32-22DB10CA53B4 Q36662114-F45E31C4-CA80-4A95-B2A0-62E9339DE8F6 Q36787173-EA840269-64D0-4BF6-8411-CC1880365C45 Q36787810-D4C45192-02C8-46FE-ABD0-1B9649513359 Q36867563-2CC8A747-7C88-4E35-8C87-2CB8C344A23C Q37051987-7AAA5A3C-C578-4D08-9441-3F3A1D5168C2 Q37108130-7E1AD125-877A-4604-BAC5-78EEDE64E8F7

P2860

Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist.

http://www.wikidata.org/entity/Q34531671

description

2003 nî lūn-bûn

@nan

2003 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի մարտին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Inhibition of endotoxin respon ...... directed endotoxin antagonist.

@ast

Inhibition of endotoxin respon ...... directed endotoxin antagonist.

@en

Inhibition of endotoxin respon ...... directed endotoxin antagonist.

@nl

type

label

Inhibition of endotoxin respon ...... directed endotoxin antagonist.

@ast

Inhibition of endotoxin respon ...... directed endotoxin antagonist.

@en

Inhibition of endotoxin respon ...... directed endotoxin antagonist.

@nl

prefLabel

Inhibition of endotoxin respon ...... directed endotoxin antagonist.

@ast

Inhibition of endotoxin respon ...... directed endotoxin antagonist.

@en

Inhibition of endotoxin respon ...... directed endotoxin antagonist.

@nl

P1433

Q34531671-A752F34A-B822-4E85-86D3-7637A05CCCA7

P1476

Q34531671-69EDB15B-9143-4071-83A9-E5FCDC3BA26F

P2093

Q34531671-110DF96D-B795-485A-98E6-0E96C5C1BD14

Q34531671-12C7959C-4ABA-48C3-B1FD-3BA0E89F18E5

Q34531671-14092361-3FDB-44AD-875E-54D20010397F

Q34531671-1BA7E23C-7065-4E43-B4A3-E5B988BA5A62

Q34531671-2480847D-DB21-4A29-A2DB-D25B9EEA097B

Q34531671-2519BE02-CF86-47F2-9E53-A16E815B830C

Q34531671-30E399C6-3256-4EDB-9B8D-8486C240471F

Q34531671-453484EA-B743-41C0-85FD-6D263831C49A

Q34531671-68BEEEC2-6020-4C60-B707-D36D3FF868BD

Q34531671-900EAA67-05D0-4A2D-A9DB-6DA3F0494F25

P304

Q34531671-02BDA597-1196-4D2E-A953-8A05E87AEE92

P31

Q34531671-A94D6E9D-CD28-4606-8C57-40F918DF2337

P356

Q34531671-4604BCE2-45D4-4654-8DE3-7AE83EF6CDDC

P407

Q34531671-1BDC0A6D-B272-462A-8176-DBC69147B856

P433

Q34531671-3A837602-A4E6-45F6-91C1-95EC2E189A41

P478

Q34531671-65DA854A-8863-4C64-9E39-ACE377827DE7

P577

Q34531671-28595524-B9F3-4E61-BB00-F55F819C1808

P698

Q34531671-50ED1C54-E502-4657-BB56-783631CEB2EF

P921

Q34531671-472C2F8B-F110-4009-8DD2-16D4D95FDF90

Q34531671-C4AB70D4-20C9-41E6-BD85-51A439FE41C4

P356

JPET.102.044487

P1433

Journal of Pharmacology and Experimental Therapeutics

P1476

Inhibition of endotoxin respon ...... directed endotoxin antagonist.

@en

P2093

Akufumi Kimura

http://www.w3.org/2001/XMLSchema#string

Daniel P Rossignol

http://www.w3.org/2001/XMLSchema#string

Fabian Gusovsky

http://www.w3.org/2001/XMLSchema#string

Jeffrey R Rose

http://www.w3.org/2001/XMLSchema#string

Jesse Chow

http://www.w3.org/2001/XMLSchema#string

John Bristol

http://www.w3.org/2001/XMLSchema#string

Maureen Mullarkey

http://www.w3.org/2001/XMLSchema#string

Melinda Przetak

http://www.w3.org/2001/XMLSchema#string

Seiichi Kobayashi

http://www.w3.org/2001/XMLSchema#string

Tsutomu Kawata

http://www.w3.org/2001/XMLSchema#string

P304

1093-1102

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1124/JPET.102.044487

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

304

http://www.w3.org/2001/XMLSchema#string

P577

2003-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12604686

http://www.w3.org/2001/XMLSchema#string

P921

Toll-like receptor